Acquisitions13 Feb 2026, 02:38 pm
Alkem MedTech to Acquire Majority Stake in Occlutech Holding for INR 1,074 Crore
AI Summary
Alkem MedTech Pvt Ltd, a wholly-owned medical devices subsidiary of Alkem Laboratories Ltd, has announced its strategic intent to acquire a majority stake in Occlutech Holding AG, a global medical devices company specialising in minimally invasive cardiac implants. The acquisition is expected to be completed by June 2026 after the regulatory approvals are obtained.
Key Highlights
- Alkem MedTech to buy up to 55% stake in Occlutech for a consideration of EUR 99.4 million (Approx. INR 1,074 crore).
- This acquisition represents a significant step in Alkem MedTech’s journey to build a global footprint and enables its entry into advanced cardiovascular devices.
- Occlutech is the second-largest company in Europe in the minimally invasive cardiac implants segment and the third-largest globally.
- In calendar year 2025, Occlutech recorded a revenue of EUR 49.4 million (unaudited), representing a 15.7% CAGR over the past three years.
- The acquisition is expected to be completed by June 2026 after the regulatory approvals are obtained.